Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T B Ledue

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Applied and Theoretical Electrophoresis : the Official Journal of the International Electrophoresis Society|January 1, 1993
The molecular weights of twelve apolipoprotein(a) variants, determined using haptoglobin 2-2 polymer molecular weight standardsW Y Craig, S E Poulin, A M DiGeorge, et al.
Journal of Autoimmunity|October 1, 1995
Anti-oxidized LDL antibodies and antiphospholipid antibodies in healthy subjects: relationship with lipoprotein- and oxidation-related analytesW Y Craig, S E Poulin, L M Neveux, et al.
Lancet (London, England)|January 8, 1994
Apolipoproteins and ischaemic heart disease: implications for screeningN J Wald, M Law, H C Watt, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Applied and Theoretical Electrophoresis : the Official Journal of the International Electrophoresis Society|January 1, 1993
The molecular weights of twelve apolipoprotein(a) variants, determined using haptoglobin 2-2 polymer molecular weight standardsW Y Craig, S E Poulin, A M DiGeorge, et al.
Journal of Autoimmunity|October 1, 1995
Anti-oxidized LDL antibodies and antiphospholipid antibodies in healthy subjects: relationship with lipoprotein- and oxidation-related analytesW Y Craig, S E Poulin, L M Neveux, et al.
Lancet (London, England)|January 8, 1994
Apolipoproteins and ischaemic heart disease: implications for screeningN J Wald, M Law, H C Watt, et al.
Pageof 3